Immune Tolerance Induction After Liver Transplantation

Clinical trial NCT07269041 · RECRUITING

Trial details

NCT number: NCT07269041
Sponsor: University of California, Los Angeles
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Liver Transplantation Immune Tolerance Immune Tolerance/Drug Effects Graft Survival Hematopoietic Stem Cell Chimerism Immunosuppression After Liver Transplantation Immunosuppression Disorders End Stage Liver Disease

Start date: 2026-02-20
Primary completion: 2029-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.